A Valuable COVID Drug Doesn't Work against New Variants

Current monoclonal antibodies fail against COVID virus variants, so drugmakers want to use a fast-track test for new ones

Related Keywords

United States ,Nassau ,New Providence ,Bahamas ,The ,American ,Myron Cohen ,Aaron Glatt ,Robert Carnahan ,Vanderbilt University Medical Center ,European Medicines Agency ,Drug Administration ,Mount Sinai South Nassau ,North Carolina ,Gillings School ,Global Public ,Vanderbilt University Medical ,Scientific American ,Christos Kyratsous ,The Coronavirus Outbreak ,Covid ,Coronavirus ,